Patent Assignment
Reel/Frame 057821/0800
Security Interest
Recorded: 2021-10-05
Pages: 18
Assignors
BAUSCH & LOMB IRELAND LIMITED
Executed: 2021-10-04
BAUSCH HEALTH COMPANIES INC.
Executed: 2021-10-04
DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH
Executed: 2021-10-04
TECHNOLAS PERFECT VISION GMBH
Executed: 2021-10-04
Assignee
THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
240 GREENWICH STREET, CORPORATE TRUST ADMINISTRATION, NEW YORK, NEW YORK, 10286
Covered Properties
(226)
Skin Cleanser Comprising a Steareth, Poloxamer and a Glyceryl Monoester
Patent:
6,589,922 →
Application:
09/802,047 →
Drug Delivery System for Hydrophobic Drugs
Aqueous Compositions Containing Metronidazole
Treating Eczema with a Combination of Isotonic Saline Ocean and Nasal Mast Cell Stabilizers
Patent:
6,596,284 →
Application:
10/063,493 →
Reduced Fluence Rate Pdt
Method to Prevent Vision Loss
Photodynamic Therapy of Occult Age-Related Macular Degeneration
Method for Reducing or Preventing Pdt Related Inflammation
Skin Cream
Patent:
7,368,122 →
Application:
10/094,534 →
Tirazole Nucleoside Analogs and Methods for Using Same
Guanylate Cyclase Receptor Agonists for the Treatment of Tissue Inflammation and Carcinogenesis
Customized Refractive Correction
Patent:
7,022,117 →
Application:
10/110,894 →
Customized Corneal Profiling
Patent:
7,237,898 →
Application:
10/110,922 →
Cornea Contact System for Laser Surgery
Laser Vision Correction Apparatus and Control Method
Treatment of Macular Edema
Closed Loop Control for Intrastromal Wavefront-Guided Ablation
System and Method for Evaluating a Secondary Lasik Treatment
Controlled Release Dosage Forms
Compositions and Methods for Delivery of Photosensitive Drugs
Synthesis and Use of 2'-Substituted-N6-Modified Nucleosides
Granular Sustained Release Preparation and Production Thereof
Injector for a Flexible Implant
Treatment of Macular Edema
Laser System and Method for Generation of a Pulse Sequence with Controllable Parameters and Computer Program Product
Reduced Fluence Rate Pdt
Eye Position Control Monitor for Laser Vision Correction
System and Method for Positioning a Patient for Laser Surgery
Beam Steering System for Corneal Laser Surgery
Method for Intrastromal Photodisruption of Dome-Shaped Surfaces
Accommodating 360 Degree Sharp Edge Optic Plate Haptic Lens
Time-Resolved Scanning Patterns for Intrastromal Surgery
Immuno-Adjuvant Pdt Treatment of Metastatic Tumors
Systems and Methods for Intrastromal Scanning Patterns
Devices and Methods for Separating Layers of Materials Having Different Ablation Thresholds
Aqueous Compositions Containing Metronidazole
Device and Method for Aligning an Eye with a Surgical Laser
Methods for Effecting Regression of Tumor Mass and Size in a Metastasized Pancreatic Tumor
Cornea Contact System
Guanylate Cyclase Receptor Agonists for the Treatment of Tissue Inflammation and Carcinogenesis
Modified Release Tablet of Bupropion Hydrochloride
Hydrolic Accommodating Intraocular Lens
Material Processing System with Variable Repetition Rate Laser
Modified Release Formulations of a Bupropion Salt
Alpha Hydroxy Acid Sustained Release Formulation
Teeth Whitening Composition and Methods
Controlled release microparticles
System and Method for Precise Beam Positioning in Ocular Surgery
Azithromycin for the Treatment of Nodular Acne
System and Method for Photoablation Using Multiple Focal Points with Rotating Beam Splitter
Stepped Microkeratome Blade Holder
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Bupropion Hydrobromide and Therapeutic Applications
Hydrolic Accommodating Intraocular Lens
Bupropion Hydrobromide and Therapeutic Applications
"W" Accommodating Intraocular Lens
Method for Intrastromal Refractive Surgery
Method for Treating Neovascularization
Modified-Release Formulations of a Bupropion Salt
Controlled Release Azithromycin Solid Dosages Forms
Methods and Compositions for Increasing Solubility of Azole Drug Compounds That Are Poorly Soluble in Water
Computer Control for Bio-Mechanical Alteration of the Cornea
Finite Element Modeling of the Cornea
Beam Steering System for Corneal Laser Surgery
System and Method for the Treatment of a Patients Eye Working at High Speed
Method for Stabilizing Polypeptides Lacking Methionine
System and Method for Altering Internal Stress Distributions to Reshape a Material
Method Patterns for Intrastromal Refractive Surgery
System and Method for Stray Light Compensation of Corneal Cuts
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Controlled Release Dosage Forms
System and Method for Refractive Surgery with Augmentation by Intrastromal Corrective Procedures
Synergistic Pharmaceutical Composition, Method of Making Same and Use of Same
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Drug Delivery System for Hydrophobic Drugs
Accommodating 360 Degree Sharp Edge Optic Plate Haptic Lens
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Photopolymerization Material for Gums Isolation
Bupropion Hydrobromide Polymorphs
Bupropion Hydrobromide and Therapeutic Applications
Agonists of Guanylate Cyclase Useful for the Treatment of Hypercholesterolemia, Atherosclerosis, Coronary Heart Disease, Gallstone, Obesity and Other Cardiovascular Diseases
Guanylate Cyclase Receptor Agonists for the Treatment of Tissue Inflammation and Carcinogenesis
System for Performing Intrastromal Refractive Surgery
Compositions and Methods for Treating Diseases of the Nail
Patent:
8,039,494 →
Application:
12/803,848 →
Granular Sustained Release Preparation and Production Thereof
Synthesis and Use of 2'-Substituted-N6-Modified Nucleosides
Stereoselective Synthesis of Metyrosine
Suspension Containing Micronized Benzoyl Peroxide
Methods and Compositions for Increasing Solubility of Azole Drug Compounds That Are Poorly Soluble in Water
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Combination of excimer laser ablation and femtosecond laser technology
Apparatus and method for providing a laser shot file
Photodynamic Therapy for Conditions of the Eye
System and Method for Precise Beam Positioning in Ocular Surgery
Compositions and Methods for Treating Diseases of the Nail
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Multidose Package, Course and Method of Treatment for Delivering Predetermined Multiple Doses of a Pharmaceutical
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
System and Method for Postoperative Capsular Bag Control
Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
System and Method with Refractive Corrections for Controlled Placement of a Laser Beam's Focal Point
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Photodynamic Therapy Laser
Method for Treating Neovascularization
Surgical Laser Unit with Variable Modes of Operation
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Method of Inhibiting Bile Acid Absorption by Administering An Agonist of a Guanylate Cyclase Receptor
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Bupropion Hydrobromide Polymorphs
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Dimensional Compensator for Use with a Patient Interface
Activation of Innate and Adaptive Immune Responses by a Ginseng Extract
Compositions for Increasing Solubility of Azole Drug Compounds That Are Poorly Soluble in Water
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Compositions and Methods for Treating Diseases of the Nail
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Process of Preparing Guanylate Cyclase C Agonists
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Method and Apparatus for Calculating a Laser Shot File for Use in an Excimer Laser
Agonists of Guanylate Cyclase and Their Uses
Compositions Useful For The Treatment Of Gastrointestinal Disorders
Agonists Of Guanylate Cyclase And Their Uses
Kinetin/Zeatin Topical Formulation
Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Stereoselective Synthesis of Metyrosine
Modified Release Formulations Of A Bupropion Salt
Compositions and Methods for Treating Diseases of the Nail
Stabilized Efinaconazole Compositions
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Anti-Infective Methods, Compositions, and Devices
Multidose Package, Course and Method of Treatment for Delivering Predetermined Multiple Doses of a Pharmaceutical
Application:
14/629,176 →
Publication:
US 2015/0174120
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Hypercholesterolemia, Atherosclerosis, Coronary Heart Disease, Gallstone, Obesity and Other Cardiovascular Diseases
Compositions and Methods for Treating Diseases of the Nail
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Photodynamic Therapy Laser
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Formulations of Calcium and Phosphate for Oral Inflammation
Compositions and Methods for Teeth Whitening
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Compositions Useful for the Treatment of Gastrointestinal Disorders
Compositions and Methods for Treating Diseases of the Nail
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Agonists of Guanylate Cyclase and Their Uses
Process of Preparing Guanylate Cyclase C Agonisys
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Kinetin/Zeatin Topical Formulation
Stabilized Efinaconazole Compositions
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Agonists of Guanylate Cyclase and Their Uses
Compositions and Methods for Treating Diseases of the Nail
Compositions and Methods for Treating Diseases of the Nail
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Kinetin/Zeatin Topical Formulation
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Formulations and Methods for Treating Ulcerative Colitis
Storage-Stable Ophthalmic Composition
Topical Pharmaceutical Compositions for Treating Skin Conditions
Compositions and Methods for Treating Diseases of the Nail
Agonists of Guanylate Cyclase and Their Uses
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Ocular Drug Delivery Devices
Multidose Package, Course and Method of Treatment for Delivering Predetermined Multiple Doses of a Pharmaceutical
Anti-Infective Methods, Compositions, and Devices
Topical Pharmaceutical Compositions for Treating Skin Conditions
Polymeric Emulsion Delivery Systems
Stabilized Efinaconazole Formulations
Agonists of Guanylate Cyclase and Their Uses
Encrypted Memory Device
Methods and Apparatus for Pumping Coolant to an Energy Delivery Device
Pain Mitigation by Mechanical Stimulation When Treating Tissue with Electromagnetic Energy
Redundant Traces for Flexible Circuits Used in an Energy Delivery Device
Methods for manufacturing phenoxyethanol
Compositions and Methods for Treating Diseases of the Nail
Topical Compositions and Methods for Treating Acne Vulgaris
Application:
16/822,831 →
Publication:
US 2020/0297684
Formulations and Methods for Treating Ulcerative Colitis
Application:
16/853,352 →
Publication:
US 2020/0316164
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
Application:
16/870,942 →
Publication:
US 2020/0325176
Agonists of Guanylate Cyclase Useful for the Treatment of Opioid Induced Dysfunctions
Application:
16/874,218 →
Publication:
US 2020/0330548
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Application:
16/882,059 →
Publication:
US 2020/0283480
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Topical Compositions
Grafted Polymer and Use Thereof
Anti-Infective Methods, Compositions, and Devices
Ophthalmic Lens Including a Peripheral Zone Having an Add-Power Offset and a Spatially-Modulated Optical Parameter
Compositions and Methods for Treating Diseases of the Nail
Application:
17/092,473 →
Publication:
US 2021/0121572
Direct Compression Molded Ophthalmic Devices
Application:
17/103,298 →
Publication:
US 2021/0162692
Stabilized Efinaconazole Compositions as Antifungals
Agonists of Guanylate Cyclase and Their Uses
Application:
17/184,256 →
Publication:
US 2021/0379142
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Application:
17/207,215 →
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Application:
17/207,222 →
Publication:
US 2021/0205406
Vitrectomy Cutter
Light Therapy Device
Patent:
921,212 →
Application:
29/720,106 →
Light Therapy Device
Patent:
922,595 →
Application:
29/720,107 →
Light Therapy Device
Patent:
928,975 →
Application:
29/720,109 →
Access Device
Patent:
940,133 →
Application:
29/720,111 →
Light Therapy Device
Patent:
959,003 →
Application:
29/780,736 →
Packaging Solutions
Application:
63/063,715 →
Molds for Production of Ophthalmic Devices
Application:
63/157,130 →
Ophthalmic Solutions
Application:
63/159,097 →
Packaging Solutions
Application:
63/159,881 →
Biomedical Devices
Application:
63/161,002 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Release of Security Interest
Mar 6, 2019
From: CRG SERVICING LLC
To: SYNERGY PHARMACEUTICALS INC.
Reel/Frame 048521/0005 →
Security Interest
Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Merger
Apr 19, 2019
From: VALEANT INTERNATIONAL BERMUDA
To: VALEANT HOLDINGS IRELAND
Reel/Frame 048939/0764 →
Assignment of Assignor's Interest
Apr 22, 2019
From: VALEANT HOLDINGS IRELAND
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 048954/0900 →
Intellectual Property Security Agreement
Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Assignment of Assignor's Interest
Aug 8, 2019
From: DOW PHARMACEUTICAL SCIENCES, INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 049999/0180 →
Assignment of Assignor's Interest
Aug 8, 2019
From: DOW PHARMACEUTICAL SCIENCES, INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 049999/0001 →
Assignment of Assignor's Interest
Oct 24, 2019
From: VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 051803/0911 →
Assignment of Assignor's Interest
Apr 9, 2020
From: SYNERGY PHARMACEUTICALS INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 052358/0134 →
Security Interest
Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
Security Agreement (First Lien)
Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien)
Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Release of Security Interest in Specified Patents (Reel/Frame 045444/0299)
Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; PF CONSUMER HEALTHCARE 1 LLC
Reel/Frame 061779/0001 →
Release of Security Interest in Specified Patents (Reel/Frame 036400/0711)
Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 061775/0826 →
Omnibus Patent Security Release Agreement (Reel/Frame 045444/0634)
Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; LABORATOIRE CHAUVIN S.A.S.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0295 →
Omnibus Patent Security Release Agreement (Reel/Frame 057821/0800)
Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: TECHNOLAS PERFECT VISION GMBH; BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 061884/0514 →
Security Agreement (First Lien)
Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061882/0708 →
Security Agreement (Second Lien)
Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 062078/0276 →
Change of Name
Jan 13, 2023
From: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
To: BAUSCH HEALTH COMPANIES INC.
Reel/Frame 062389/0306 →
Assignment of Assignor's Interest
Jan 13, 2023
From: BAUSCH HEALTH COMPANIES INC.
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 062375/0428 →
Release of Security Interest in Specified Patents (Reel/Frame 045444/0299)
Apr 17, 2024
From: BARCLAYS BANK PLC
To: BAUSCH + LOMB IRELAND LIMITED; BAUSCH + LOMB CORPORATION
Reel/Frame 067131/0587 →
Omnibus Patent Security Release Agreement (Reel/Frame 057821/0800)
Apr 17, 2024
From: THE BANK OF NEW YORK MELLON
To: BAUSCH + LOMB IRELAND LIMITED; BAUSCH + LOMB CORPORATION
Reel/Frame 067131/0651 →
Omnibus Patent Security Release Agreement (Reel/Frame 049672/0652)
Apr 17, 2024
From: THE BANK OF NEW YORK MELLON
To: BAUSCH + LOMB IRELAND LIMITED; BAUSCH + LOMB CORPORATION
Reel/Frame 067131/0618 →